News | December 03, 2006

Docs Should Alert ICD/Pacemaker Patients About Magnets

Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”

A release from the Heart Rhythm Society reports that researchers found that while common magnets for home and office use with low magnetic strength posed little risk, stronger magnets made from neodymium-iron-boron (NdFeB) may cause interference with cardiac devices and pose potential hazards to patients. NdFeB magnets are increasingly being used in homes and office products, toys, jewelry and even clothing.

“Physicians should caution patients about the risks associated with these magnets,” says Thomas Wolber, a cardiologist at the University Hospital of Zurich in Switzerland and lead author of the study. “We also recommend that the packaging include information on the potential risks that may be associated with these types of magnets.”

Two spherical magnets of eight and 10 millimeters in diameter and one necklace made of 45 spherical magnets were tested on 70 patients, 41 with pacemakers and 29 with ICDs. Magnetic interference was observed in all patients. The cardiac devices resumed normal function after the magnets were removed.

“This study is timely and important to attract the attention of both the public and the medical profession about the potentially serious health consequences of magnets used in decoration products... for an ICD patient, the magnet interference can be fatal,” writes Huagui Li, M.D., a cardiologist at the Minnesota Heart Clinic in Edina, MN, in an accompanying “Heart Rhythm” editorial.

Dr. Li concludes that manufacturers who use magnets should be required to put warning labels on their products for optimal patient safety.

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init